Anti-TNF-α Monoclonal Antibody Therapy Improves Anemia through Downregulating Hepatocyte Hepcidin Expression in Inflammatory Bowel Disease

Table 1

The clinical characteristics of IBD patients and healthy volunteers.

	HC	UC (A/R)^b	CD (A/R)^b
Patients	22	22/11	25/41
Age, years (range)	(15-67)	(12-79)	(11-89)
Gender (M/F)	13/9	18/15	34/32
Medical therapy received
5-ASA		19	40
Immunosuppressants		14	26
Biologics		0	0
Disease extent^a
Proctosigmoiditis (E1)		10
Left-sided colitis (E2)		9
Extensive colitis (E3)		14
Disease location^a
Ileum only (L1)			21
Colon only (L2)			18
Ileum and colon (L3)			16
Upper gastrointestinal tract (L4a)			11

^aMontreal classification; ^bA/R: active/remission.